{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T03:04:08Z","timestamp":1780023848181,"version":"3.53.1"},"reference-count":49,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T00:00:00Z","timestamp":1775174400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004063","name":"Knut and Alice Wallenberg Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004063","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001862","name":"the Swedish Research Council","doi-asserted-by":"crossref","award":["2023-01942"],"award-info":[{"award-number":["2023-01942"]}],"id":[{"id":"10.13039\/501100001862","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Atypical femur fractures (AFF) are rare stress fractures linked to long-term bisphosphonate (BP) use. However, since some patients develop AFF without BP exposure (BP-na\u00efve), additional mechanisms have been proposed. In this study, we tested medication use, clinical characteristics, and femoral geometry. We started with a hypothesis that BP-na\u00efve patients would have additional risk factors in these areas compared with BP-users. We included 172 patients aged \u226555\u00a0yr who sustained AFF in Sweden between 2008 and 2010. Among them, 134 had used BPs prior to the fracture and 38 had not. All fractures met the 2014 ASBMR major criteria for AFF. Data on medication use, comorbidities, and demographics were extracted from national registers, and radiographs were reviewed to assess femoral geometry. All statistical models were adjusted for sex and age. We found that among BP-na\u00efve patients, male sex was more common (21.1%) than among BP-users (3.0%). Additionally, BP-na\u00efve patients were less likely to use calcium supplementation (23.7% vs 90.3%, OR 0.04, 95% CI 0.01-0.10), corticosteroids (13.2% vs 35.8%, OR 0.18, 95% CI 0.05-0.52), proton pump inhibitors (23.7% vs 41.8%, OR 0.36, 95% CI 0.14-0.85), and beta-blockers (28.9% vs 47.0%, OR 0.43, 95% CI 0.18-0.97). Moreover, BP-na\u00efve patients had fewer diagnosed bone disorders, including osteoporosis (5.3% vs 34.3%, OR 0.10, 95% CI 0.02-0.38). Bisphosphonate-na\u00efve patients did have a higher lateral-to-medial cortical thickness ratio (1.00 vs 0.90, p\u2009&amp;lt;\u2009.01); however, other geometric differences were minor and did not support the hypothesis. The absence of identifiable mechanisms for stress fracture formation suggests that future research should test factors not captured in registry data or femoral geometry. Possibly, physical activity levels or subtle bone metabolic conditions may be contributing to the pathogenesis of AFF, particularly in BP-na\u00efve individuals.<\/jats:p>","DOI":"10.1093\/jbmrpl\/ziag059","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T11:41:30Z","timestamp":1775043690000},"source":"Crossref","is-referenced-by-count":0,"title":["Risk factors for atypical femur fractures with and without bisphosphonate treatment: a national nested case-control study"],"prefix":"10.1093","volume":"10","author":[{"given":"Rasmus","family":"Mikiver","sequence":"first","affiliation":[{"name":"Department of Biomedical and Clinical Sciences, Link\u00f6ping University , 581 83, Link\u00f6ping ,","place":["Sweden"]},{"name":"Clinical Department of Orthopaedics in Link\u00f6ping, Region \u00d6sterg\u00f6tland , 581 83, Link\u00f6ping ,","place":["Sweden"]},{"name":"Department of Health, Medicine, and Caring Sciences, Link\u00f6ping University , 581 83, Link\u00f6ping ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rickard","family":"Sand","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Clinical Sciences, Link\u00f6ping University , 581 83, Link\u00f6ping ,","place":["Sweden"]},{"name":"Clinical Department of Orthopaedics in Link\u00f6ping, Region \u00d6sterg\u00f6tland , 581 83, Link\u00f6ping ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans Peter","family":"B\u00f6gl","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Clinical Sciences, Link\u00f6ping University , 581 83, Link\u00f6ping ,","place":["Sweden"]},{"name":"Clinical Department of Orthopedic Surgery in G\u00e4vle, Region G\u00e4vleborg , 801 87, G\u00e4vle ,","place":["Sweden"]},{"name":"Centre for Research and Development, Uppsala University , 801 87, G\u00e4vle ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Zdolsek","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Clinical Sciences, Link\u00f6ping University , 581 83, Link\u00f6ping ,","place":["Sweden"]},{"name":"Clinical Department of Orthopaedics in Link\u00f6ping, Region \u00d6sterg\u00f6tland , 581 83, Link\u00f6ping ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daphne","family":"Wezenberg","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Clinical Sciences, Link\u00f6ping University , 581 83, Link\u00f6ping ,","place":["Sweden"]},{"name":"Clinical Department of Orthopaedics in Link\u00f6ping, Region \u00d6sterg\u00f6tland , 581 83, Link\u00f6ping ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Mich\u00e4elsson","sequence":"additional","affiliation":[{"name":"Department of Surgical Sciences-Medical Epidemiology, Uppsala University , 751 85, Uppsala ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4988-6346","authenticated-orcid":false,"given":"Johan","family":"Lyth","sequence":"additional","affiliation":[{"name":"Department of Health, Medicine, and Caring Sciences, Link\u00f6ping University , 581 83, Link\u00f6ping ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0677-9265","authenticated-orcid":false,"given":"J\u00f6rg","family":"Schilcher","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Clinical Sciences, Link\u00f6ping University , 581 83, Link\u00f6ping ,","place":["Sweden"]},{"name":"Clinical Department of Orthopaedics in Link\u00f6ping, Region \u00d6sterg\u00f6tland , 581 83, Link\u00f6ping ,","place":["Sweden"]},{"name":"Wallenberg Center for Molecular Medicine, Link\u00f6ping University , 581 83, Link\u00f6ping ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,4,3]]},"reference":[{"key":"2026052822570362100_ref1","doi-asserted-by":"publisher","first-page":"1759720x20916983","DOI":"10.1177\/1759720x20916983","article-title":"Atypical femur fractures: current understanding and approach to management","volume":"12","author":"Tile","year":"2020","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"1","key":"2026052822570362100_ref2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jbmr.1998","article-title":"Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research","volume":"29","author":"Shane","year":"2014","journal-title":"J Bone Miner Res"},{"issue":"6","key":"2026052822570362100_ref3","doi-asserted-by":"publisher","first-page":"e327","DOI":"10.5435\/jaaos-d-22-00476","article-title":"Real-world management of patients with osteoporosis at very high risk of fracture","volume":"31","author":"Diffenderfer","year":"2023","journal-title":"J Am Acad Orthop Surg"},{"issue":"1","key":"2026052822570362100_ref4","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3109\/17453674.2015.1004149","article-title":"Risk of atypical femoral fracture during and after bisphosphonate use","volume":"86","author":"Schilcher","year":"2015","journal-title":"Acta Orthop"},{"issue":"18","key":"2026052822570362100_ref5","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1056\/NEJMoa1010650","article-title":"Bisphosphonate use and atypical fractures of the femoral shaft","volume":"364","author":"Schilcher","year":"2011","journal-title":"N Engl J Med"},{"issue":"8","key":"2026052822570362100_ref6","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1056\/NEJMoa1916525","article-title":"Atypical femur fracture risk versus fragility fracture prevention with bisphosphonates","volume":"383","author":"Black","year":"2020","journal-title":"N Engl J Med"},{"issue":"1","key":"2026052822570362100_ref7","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s12603-015-0652-3","article-title":"Epidemiology and postoperative outcomes of atypical femoral fractures in older adults: a systematic review","volume":"21","author":"Khow","year":"2017","journal-title":"J Nutr Health Aging"},{"key":"2026052822570362100_ref8","doi-asserted-by":"publisher","first-page":"1063170","DOI":"10.3389\/fsurg.2022.1063170","article-title":"A brief review and clinical evidences of teriparatide therapy for atypical femoral fractures associated with long-term bisphosphonate treatment","volume":"9","author":"Gao","year":"2022","journal-title":"Front Surg"},{"issue":"2","key":"2026052822570362100_ref9","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.bone.2013.02.004","article-title":"Proposed pathogenesis for atypical femoral fractures: lessons from materials research","volume":"55","author":"Ettinger","year":"2013","journal-title":"Bone"},{"issue":"33","key":"2026052822570362100_ref10","doi-asserted-by":"publisher","first-page":"8722","DOI":"10.1073\/pnas.1704460114","article-title":"Atypical fracture with long-term bisphosphonate therapy is associated with altered cortical composition and reduced fracture resistance","volume":"114","author":"Lloyd","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"2026052822570362100_ref11","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1302\/2046-3758.610.Bjr-2016-0321.R1","article-title":"The effect of long-term bisphosphonate therapy on trabecular bone strength and microcrack density","volume":"6","author":"Jin","year":"2017","journal-title":"Bone Joint Res"},{"issue":"4","key":"2026052822570362100_ref12","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1002\/jbmr.2748","article-title":"Incidence and characteristics of atypical femoral fractures: clinical and geometrical data","volume":"31","author":"Mahjoub","year":"2016","journal-title":"J Bone Miner Res"},{"key":"2026052822570362100_ref13","doi-asserted-by":"publisher","first-page":"104803","DOI":"10.1016\/j.jmbbm.2021.104803","article-title":"Biomechanical mechanisms of atypical femoral fracture","volume":"124","author":"Ural","year":"2021","journal-title":"J Mech Behav Biomed Mater"},{"issue":"12","key":"2026052822570362100_ref14","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1001\/archinternmed.2012.1796","article-title":"Increasing occurrence of atypical femoral fractures associated with bisphosphonate use","volume":"172","author":"Meier","year":"2012","journal-title":"Arch Intern Med"},{"issue":"12","key":"2026052822570362100_ref15","doi-asserted-by":"publisher","first-page":"2544","DOI":"10.1002\/jbmr.1719","article-title":"Incidence of atypical nontraumatic diaphyseal fractures of the femur","volume":"27","author":"Dell","year":"2012","journal-title":"J Bone Miner Res"},{"issue":"5","key":"2026052822570362100_ref16","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1002\/jbmr.1550","article-title":"Incidence and demography of femur fractures with and without atypical features","volume":"27","author":"Feldstein","year":"2012","journal-title":"J Bone Miner Res"},{"key":"2026052822570362100_ref17","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgae023","article-title":"Bisphosphonate use and risk of atypical femoral fractures: a Danish case cohort study with blinded radiographic review","volume":"109","author":"Bauer","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2026052822570362100_ref18","doi-asserted-by":"publisher","first-page":"319","DOI":"10.3109\/17453674.2012.718517","article-title":"Highly different risk estimates for atypical femoral fracture with use of bisphosphonates - debate must be allowed!","volume":"83","author":"Rydholm","year":"2012","journal-title":"Acta Orthop"},{"issue":"2","key":"2026052822570362100_ref19","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.bone.2010.05.019","article-title":"Atypical fractures of the femur and bisphosphonate therapy: a systematic review of case\/case series studies","volume":"47","author":"Giusti","year":"2010","journal-title":"Bone"},{"key":"2026052822570362100_ref20","doi-asserted-by":"publisher","first-page":"421","DOI":"10.2340\/17453674.2025.43899","article-title":"Comparing incomplete atypical femur fractures in patients with or without bisphosphonate treatment: radiography and bone morphology in a retrospective study of 19 cases","volume":"96","author":"Zdolsek","year":"2025","journal-title":"Acta Orthop"},{"issue":"6","key":"2026052822570362100_ref21","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1002\/jbmr.4801","article-title":"Prevalence of monogenic bone disorders in a Dutch cohort of atypical femur fracture patients","volume":"38","author":"Zhou","year":"2023","journal-title":"J Bone Miner Res"},{"key":"2026052822570362100_ref22","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.bone.2016.01.002","article-title":"The association of race\/ethnicity and risk of atypical femur fracture among older women receiving oral bisphosphonate therapy","volume":"85","author":"Lo","year":"2016","journal-title":"Bone"},{"key":"2026052822570362100_ref23","doi-asserted-by":"publisher","first-page":"116455","DOI":"10.1016\/j.bone.2022.116455","article-title":"Characteristics of bisphosphonate and non-bisphosphonate related atypical femoral fracture in a South East Asian population - secondary analysis","volume":"162","author":"Gani","year":"2022","journal-title":"Bone"},{"key":"2026052822570362100_ref24","doi-asserted-by":"publisher","first-page":"4753170","DOI":"10.1155\/2016\/4753170","article-title":"Atypical complete femoral fractures associated with bisphosphonate use or not associated with bisphosphonate use: is there a difference?","volume":"2016","author":"Kim","year":"2016","journal-title":"Biomed Res Int"},{"issue":"2","key":"2026052822570362100_ref25","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s10654-016-0117-y","article-title":"Registers of the Swedish total population and their use in medical research","volume":"31","author":"Ludvigsson","year":"2016","journal-title":"Eur J Epidemiol"},{"issue":"11","key":"2026052822570362100_ref26","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1007\/s00198-018-4640-4","article-title":"Incidence, risk factors, and fracture healing of atypical femoral fractures: a multicenter case-control study","volume":"29","author":"Lim","year":"2018","journal-title":"Osteoporos Int"},{"key":"2026052822570362100_ref27","doi-asserted-by":"publisher","DOI":"10.56929\/jseaortho-2025-0234","article-title":"Femoral geometry in bisphosphonate-related atypical femoral fracture and bisphosphonate-na\u00efve atypical femoral fracture","volume":"49","author":"Songsantiphap","year":"2025","journal-title":"J Southeast Asian Orthop"},{"key":"2026052822570362100_ref28","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.bone.2015.10.016","article-title":"Assessment of femur geometrical parameters using EOS imaging technology in patients with atypical femur fractures; preliminary results","volume":"83","author":"Morin","year":"2016","journal-title":"Bone"},{"issue":"11","key":"2026052822570362100_ref29","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1002\/jbmr.2547","article-title":"Atypical fractures are mainly subtrochanteric in Singapore and diaphyseal in Sweden: a cross-sectional study","volume":"30","author":"Schilcher","year":"2015","journal-title":"J Bone Miner Res"},{"issue":"4","key":"2026052822570362100_ref30","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afae080","article-title":"Barriers and motivators to undertaking physical activity in adults over 70-a systematic review of the quantitative literature","volume":"53","author":"Kilgour","year":"2024","journal-title":"Age Ageing"},{"issue":"1","key":"2026052822570362100_ref31","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41533-020-0162-6","article-title":"A retrospective database study of oral corticosteroid and bisphosphonate prescribing patterns in England","volume":"30","author":"Chalitsios","year":"2020","journal-title":"NPJ Prim Care Respir Med"},{"issue":"8","key":"2026052822570362100_ref32","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1023\/a:1016495221567","article-title":"What the gastroenterologist should know about the gastrointestinal safety profiles of bisphosphonates","volume":"47","author":"Graham","year":"2002","journal-title":"Dig Dis Sci"},{"issue":"4","key":"2026052822570362100_ref33","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1007\/s00198-012-2112-9","article-title":"The effect of proton pump inhibitors on fracture risk: report from the Canadian Multicenter Osteoporosis Study","volume":"24","author":"Fraser","year":"2013","journal-title":"Osteoporos Int"},{"issue":"9","key":"2026052822570362100_ref34","doi-asserted-by":"publisher","first-page":"775","DOI":"10.2165\/00002018-200932090-00002","article-title":"Low-energy femoral fractures associated with the long-term use of bisphosphonates: a case series from a Swiss university hospital","volume":"32","author":"Ing-Lorenzini","year":"2009","journal-title":"Drug Saf"},{"issue":"1","key":"2026052822570362100_ref35","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41368-022-00193-1","article-title":"Targeted inhibition of osteoclastogenesis reveals the pathogenesis and therapeutics of bone loss under sympathetic neurostress","volume":"14","author":"Sui","year":"2022","journal-title":"Int J Oral Sci"},{"issue":"11","key":"2026052822570362100_ref36","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1161\/hypertensionaha.123.21648","article-title":"Advanced progress of the relationship between antihypertensive drugs and bone metabolism","volume":"80","author":"Zhang","year":"2023","journal-title":"Hypertension"},{"issue":"1","key":"2026052822570362100_ref37","doi-asserted-by":"publisher","first-page":"70","DOI":"10.5704\/moj.1303.002","article-title":"Spontaneous subtrochanteric femoral stress fracture related to alendronate: a case report","volume":"7","author":"Chew","year":"2013","journal-title":"Malays Orthop J"},{"issue":"3","key":"2026052822570362100_ref38","doi-asserted-by":"publisher","first-page":"286.e2","DOI":"10.12809\/hkmj144384","article-title":"Bisphosphonate-associated atypical femur fracture in a 90-year-old Caucasian woman","volume":"21","author":"Gopinath","year":"2015","journal-title":"Hong Kong Med J"},{"key":"2026052822570362100_ref39","doi-asserted-by":"publisher","first-page":"101112","DOI":"10.1016\/j.bonr.2021.101112","article-title":"Bilateral atypical fractures of the femur: ten years AFTER ten years of bisphosphonate therapy","volume":"15","author":"Smith","year":"2021","journal-title":"Bone Rep"},{"issue":"5","key":"2026052822570362100_ref40","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1111\/j.1365-2796.2008.02065.x","article-title":"Atrial fibrillation in fracture patients treated with oral bisphosphonates","volume":"265","author":"Abrahamsen","year":"2009","journal-title":"J Intern Med"},{"issue":"3","key":"2026052822570362100_ref41","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1007\/s11999-013-3352-5","article-title":"Are race and sex associated with the occurrence of atypical femoral fractures?","volume":"472","author":"Marcano","year":"2014","journal-title":"Clin Orthop Relat Res"},{"key":"2026052822570362100_ref42","doi-asserted-by":"publisher","first-page":"115453","DOI":"10.1016\/j.bone.2020.115453","article-title":"Biological activity is not suppressed in mid-shaft stress fracture of the bowed femoral shaft unlike in \"typical\" atypical subtrochanteric femoral fracture: a proposed theory of atypical femoral fracture subtypes","volume":"137","author":"Oh","year":"2020","journal-title":"Bone"},{"issue":"4","key":"2026052822570362100_ref43","doi-asserted-by":"publisher","DOI":"10.1002\/jbm4.10607","article-title":"Asian ethnicity and femoral geometry in atypical femur fractures: independent or interdependent risk factors?","volume":"6","author":"Dhanekula","year":"2022","journal-title":"JBMR Plus"},{"issue":"7","key":"2026052822570362100_ref44","doi-asserted-by":"publisher","first-page":"ziaf071","DOI":"10.1093\/jbmrpl\/ziaf071","article-title":"Association of exercise and race\/ethnicity with atypical femur fracture","volume":"9","author":"Adams","year":"2025","journal-title":"JBMR Plus"},{"issue":"1","key":"2026052822570362100_ref45","doi-asserted-by":"publisher","first-page":"19974","DOI":"10.1038\/s41598-024-71024-y","article-title":"Comparison of bone turnover suppression in atypical femoral fractures and osteoporotic hip fractures","volume":"14","author":"Ahn","year":"2024","journal-title":"Sci Rep"},{"issue":"1","key":"2026052822570362100_ref46","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s00223-019-00546-9","article-title":"A genome-wide association study of bisphosphonate-associated atypical femoral fracture","volume":"105","author":"Kharazmi","year":"2019","journal-title":"Calcif Tissue Int"},{"issue":"8","key":"2026052822570362100_ref47","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.clinbiomech.2014.08.001","article-title":"Femoral shaft strains during daily activities: implications for atypical femoral fractures","volume":"29","author":"Martelli","year":"2014","journal-title":"Clin Biomech (Bristol)"},{"issue":"3","key":"2026052822570362100_ref48","doi-asserted-by":"publisher","first-page":"2309499019881475","DOI":"10.1177\/2309499019881475","article-title":"Reliability of measuring lateral bowing angle of the femur in patients with atypical femur fractures","volume":"27","author":"Lee","year":"2019","journal-title":"J Orthop Surg (Hong Kong)"},{"issue":"7139","key":"2026052822570362100_ref49","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1136\/bmj.316.7139.1236","article-title":"What's wrong with Bonferroni adjustments","volume":"316","author":"Perneger","year":"1998","journal-title":"BMJ"}],"container-title":["JBMR Plus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jbmrplus\/advance-article-pdf\/doi\/10.1093\/jbmrpl\/ziag059\/67783695\/ziag059.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmrplus\/article-pdf\/10\/6\/ziag059\/67783695\/ziag059.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmrplus\/article-pdf\/10\/6\/ziag059\/67783695\/ziag059.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T02:57:11Z","timestamp":1780023431000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmrplus\/article\/doi\/10.1093\/jbmrpl\/ziag059\/8586491"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,3]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,5,9]]}},"URL":"https:\/\/doi.org\/10.1093\/jbmrpl\/ziag059","relation":{},"ISSN":["2473-4039"],"issn-type":[{"value":"2473-4039","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,6]]},"published":{"date-parts":[[2026,4,3]]},"article-number":"ziag059"}}